In a surprising announcement, President Trump declared a 100% tariff on patented pharmaceuticals unless companies manufacture in the U.S., leaving many confused about the implications for drug prices and healthcare.
In a surprising twist, President Trump hints at tariff exemptions for certain electronic products from China. As tensions rise, will this signal a change in strategy or is it just a temporary pause?
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
